RHHBY Financial Statements & Analysis
Complete financial statements for RHHBY including income statement, balance sheet, and cash flow statement. Analyze RHHBY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
57
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
3.2% ↑
Net Income
-28.0% ↓
Gross Margin
1.3% ↑
Operating Margin
-15.6% ↓
Balance Sheet
Current Ratio
10.0% ↑
Debt to Equity
9.0% ↓
Asset Turnover
-8.3% ↓
Cash Flow
Operating Cash Flow
24.8% ↑
Net Cash Flow
315.3% ↑
Free Cash Flow
31.8% ↑
Cash Flow to Debt
5.7% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
Metric | 2023 | 2024 | Change | Impact |
---|---|---|---|---|
Revenue | 60.44B | 62.40B | 3.2% | |
Gross Profit | 44.08B | 46.11B | 4.6% | |
Operating Income | 15.39B | 13.42B | 12.8% | |
Net Income | 11.50B | 8.28B | 28.0% | |
EPS | 1.8 | 1.3 | 27.8% | |
EBITDA | 18.41B | 16.62B | 9.7% | |
Gross Margin | 72.94% | 73.90% | 1.3% | |
Operating Margin | 25.47% | 21.50% | 15.6% | |
Net Income Margin | 19.02% | 13.27% | 30.3% | |
R&D Expenses | 14.20B | 15.30B | 7.8% |
Income Statement Full Table
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 62.40B | 60.44B | 63.28B | 62.80B | 58.32B |
Gross Profit | 46.11B | 44.08B | 44.44B | 43.10B | 41.97B |
Operating Income | 13.42B | 15.39B | 18.18B | 17.28B | 17.73B |
Net Income | 8.28B | 11.50B | 12.42B | 13.93B | 14.29B |
EPS | 1.3 | 1.8 | 1.94 | 2.05 | 2.09 |
EBITDA | 16.62B | 18.41B | 20.80B | 22.19B | 22.97B |
Gross Margin | 73.90% | 72.94% | 70.23% | 68.63% | 71.96% |
Operating Margin | 21.50% | 25.47% | 28.72% | 27.52% | 30.40% |
Net Income Margin | 13.27% | 19.02% | 19.63% | 22.18% | 24.51% |
R&D Expenses | 15.30B | 14.20B | 14.05B | 13.71B | 12.15B |